Nanopharm-logo-with-signature-Pantone (1)
Close this search box.

Accelerate DPI Clinical Success with Innovative De-Risking Strategy

Bearded and gloved scientist in white lab coat administers nasal spray to Nanopharm's Nasal CAST in-vitro deposition model.

Download Presentation Discover the comprehensive session of ‘Empowering the Path to Clinical: Innovative Strategies for De-Risking DPI Product Development’ from RDD 2024. This workshop, expertly hosted by Aptar Pharma and Nanopharm, an Aptar Pharma company, in Tucson, Arizona, provides a deep dive into the multi-faceted approach required for successful dry powder inhaler (DPI) development. The […]